Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
Recognized by America's Top Doctors, 2007, 2008, 2010, 2012 - 2018
Recognized by Best Doctors in America 2003 - 2018
Recognized annually in Philadelphia magazine's Top Docs issue from 2004 to 2019
Internal Medicine, 1989
Perelman Center for Advanced Medicine
South Pavilion, 4th Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Lau CT, Gefter WB, Metz DC: Radiographic appearance of a catheter-free wireless esophageal pH probe Am J Roentgenol 184 : S40-42,2005.
Shih GL, Brensinger C, Katzka DA, Metz DC: Postprandial esophageal integrated acidity is a reliable predictor of GERD Aliment Pharmacol Therap 21 : 1475-1482,2005.
Metz DC, Miner PB, Heuman DM, Chen Y, Sostek M: Comparison of the effects of intravenously and orally administered esomeprazole on acid output in patients with symptoms of gastro-esophageal reflux disease Aliment Pharmacol Therap 22 : 813-821,2005.
Metz DC, Comer GM, Soffer E, Forsmark CE, Cryer B, Chey W, Pisegna JR: Three year oral pantoprazole administration is effective for patients with Zollinger-Ellison syndrome and other hypersecretory conditions Aliment Pharmacol Therap 23 : 437-444,2006.
Pratha V, Hogan DL, Lynn RB, Field B, Metz DC: Intravenous Pantoprazole as Initial Treatment in Patients With Gastroesophageal Reflux Disease and a History of Erosive Esophagitis: A Randomized Clinical Trial Dig Dis Sci 51 : 1595-1601,2006.
Blonski WC, Shih GL, Brensinger CM, Katzka DA, Metz DC: Analysis of the acidity index and integrated intragastric acidity in 645 patients presenting with gastroesophageal reflux disease symptoms Sc J Gastroenterol 41 : 382-389,2006.
Yang YX, Lewis JD, Epstein S, Metz DC: Chronic proton pump inhibitor therapy and hip fracture risk JAMA 296 : 1595-1601,2006.
Lewis JD, Strom BL, Kimmel SE, Farrar J, Metz DC, Brensinger C, Nessel L, Localio AR: Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure Pharmacoepidemiol Drug Saf 15 : 39-45,2006.
Howden C, Metz DC, Hunt B, Majid V, Kukulka M, Amer F, Samra N.: Dose-Response Evaluation of the Antisecretory Effect of Continuous Infusion Intravenous Lansoprazole Regimens over 48 Hours Aliment Pharmacol Therap 23 : 975-984,2006.
Metz DC, Amer F, Hunt B, Majid V, Kukulka M.: Lansoprazole Regimens That Sustain Intragastric pH >6: An Evaluation of Intermittent Oral and Continuous IV Infusion Dosages Aliment Pharmacol Therap 23 : 985-995,2006.
3400 Civic Center Boulevard709 Perelman Center for Advanced MedicineSouth Pavilion
Phone: (215) 662-3541
Patient appointments: 800-789-7366
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.